戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 nthetic genome that can be used to produce a synthetic cell.
2 rk for the development of a self-replicating synthetic cell.
3 ate partial molecular self-regeneration in a synthetic cell.
4 artificial cortices for the stabilization of synthetic cells.
5 d in biomedicine, biosensing or for building synthetic cells.
6 gineering advanced biomimetic agents such as synthetic cells.
7 s both structural and functional elements of synthetic cells.
8  tunable platform for programming release is synthetic cells.
9 ology, biosensing, targeted drug release, or synthetic cells.
10 lecular gates for drug delivery, or to build synthetic cells.
11 NA materials to mimic life-like functions in synthetic cells.
12 mplified pathways for membrane generation in synthetic cells.
13 lar transport in biosensing, sequencing, and synthetic cells.
14 , showing promise in building biosensors and synthetic cells.
15 on of functionalities in both biological and synthetic cells.
16 ent key early steps in the reconstitution of synthetic cells.
17  have utility in the construction of minimal synthetic cells.
18 nally, structurally and functionally complex synthetic cells.
19  as whole-cell models and the engineering of synthetic cells.
20 ally for use with biological logic gates and synthetic cells.
21 design principles for conferring motility to synthetic cells.
22  design, and the construction of minimal and synthetic cells.
23 neous again, with infrequent division of the synthetic cells.
24  sensing, drug delivery, and the creation of synthetic cells.
25 ssembly of new infectious virions within the synthetic cells.
26 res at the cortex or within the lumen of the synthetic cells.
27 esting, biophysical studies and their use as synthetic cells.
28  and opening up its use in the generation of synthetic cells.
29 romolecular machines, metabolic networks and synthetic cells.
30 l strategy towards the bottom-up assembly of synthetic cells.
31 trafast bioengineered systems such as active synthetic cells.
32 pid release of molecules encapsulated within synthetic cells.
33 esicles as a way to automate the assembly of synthetic cells.
34 membrane proteins, and provide a chassis for synthetic cells.
35 ly, structurally and morphologically complex synthetic cells.
36 e(3)O(4) nanoparticles and embedding them in synthetic cells.
37                So far, genetic regulation of synthetic cell activity has been largely confined to che
38            Here we show that a wide array of synthetic cell adhesion molecules can be generated by co
39                            The modularity of synthetic cell adhesion molecules provides fundamental i
40  identity of the intracellular domain of the synthetic cell adhesion molecules specifies interface mo
41           Projects such as BaSyC (Building a Synthetic Cell) aim to build an entity that mimics how l
42  organize biochemical processes in cells and synthetic cell analogues.
43 , quorum-sensing-based communication between synthetic cells and bacteria was controlled with light.
44 ular communication mechanisms engineered for synthetic cells and classify them based on their resembl
45 ined fashion, with potential applications in synthetic cells and nanoreactors.
46  provide a platform to engineer functions of synthetic cells and protocells.
47 ould be exploited in the bottom-up design of synthetic cells and tissues, to the generation of smart
48 lucidate complex cellular mechanisms, create synthetic cells, and discover new therapeutics.
49 hemicals, constructing metabolic modules for synthetic cells, and even enabling molecular computation
50 crodroplets are finding increased utility in synthetic cell applications due to their cytomimetic pro
51                                    Bottom-up synthetic cells are as a platform for replicating and pr
52 rogress in this field, including areas where synthetic cells are having socioeconomic and technologic
53 ncement is key to unlocking the potential of synthetic cells as cell models and as microdevices in bi
54 ould unlock a wide range of applications for synthetic cells as programmable micromachines in biomedi
55 o build up genetic complexity in an evolving synthetic cell, as well as to study evolutionary process
56                          We demonstrate that synthetic cells based on droplet-supported lipid bilayer
57                                            A synthetic cell-binding peptide (P-15) combined with anor
58                                            A synthetic cell-binding peptide (P-15) combined with anor
59                                The role of a synthetic cell-binding peptide (P-15), combined with ano
60 ese results suggest that the use of the P-15 synthetic cell-binding peptide combined with ABM yields
61 ese results suggest that the use of the P-15 synthetic cell-binding peptide combined with ABM yields
62 erived hydroxyapatite matrix combined with a synthetic cell-binding peptide P-15 (Putty P15) to deter
63 ith a bovine-derived xenograft coated with a synthetic cell-binding peptide; then the test group rece
64         Our work provides a foundation for a synthetic cell biology in which multi-protein macroscale
65  Immunopharma) is a customizable, degradable synthetic cell biomimetic that emulates physiologic, cel
66 etic biology is to enhance the complexity of synthetic cells by establishing functional compartmental
67                                        Here, synthetic cells, called nanoreactors, are engineered for
68                                              Synthetic cells can be constructed from diverse molecula
69                          Additionally, these synthetic cells can be efficiently removed from T cells
70        Encased in a lipid bilayer structure, synthetic cells can be outfitted with molecular conduits
71       An open question is whether simplified synthetic cells can gain similar complex functionality b
72                   These findings demonstrate synthetic cells capable of autonomous circadian rhythms
73                          Here we introduce a synthetic cell-cell adhesin logic with swarming bacteria
74 face patterns(2,9) is still very limited, as synthetic cell-cell adhesion toolkits and suitable patte
75                          The construction of synthetic cell-cell communication networks can improve o
76 ave applications ranging from drug design to synthetic cell circuits.
77 sed cell-cell interactions inferred from the synthetic cells closely resemble the original data, achi
78 mic control over protein distribution within synthetic cells comprising a lipid bilayer membrane surr
79           The flexible and modular design of synthetic cells, comprising lipid vesicles capable of im
80  synthetic cell modules and augmented living/synthetic cell constructs with potential applications in
81 , we pave the way for the development of new synthetic cell constructs.
82                                              Synthetic cells containing genetic programs and protein
83 oluble Abeta oligomers from several sources (synthetic, cell culture, human brain extracts) facilitat
84 us work expressing membrane pore proteins in synthetic cells demonstrated content exchange, user-defi
85 ll-free protein expression and vesicle-based synthetic cell design to create cell-sized capsules able
86 ble tool for synthetic biology and bottom-up synthetic cell design.
87 agnetic field, which is absent from existing synthetic cell designs.
88 polymersomes are particularly attractive for synthetic cell development and drug delivery systems.
89            In the framework of artificial or synthetic cell development, giant liposomes are common b
90 plored, molecular crowding at the surface of synthetic cells emerges as an additional development wit
91      In the bioengineered world, advances in synthetic cell engineering and biorobotics have created
92 this study contributes to the development of synthetic cells, enhancing our understanding of the mini
93 cell-free viral cycle where T7 phages infect synthetic cells, equipped with lipopolysaccharides on th
94 olling a wide range of in vitro chemistries, synthetic cell-free biochemical circuits promise to be u
95 port here on the development of a completely synthetic cell-free therapy based on peptide amphiphile
96 (CV) protocol introduces an efficient, fully synthetic, cell-free approach for preparing gRNA express
97 lates, in situ gene expression and, thereby, synthetic cell function can be controlled according to s
98                              So far, a fully synthetic cell has remained elusive, but chemists are pr
99 loped novel criteria for evaluating how well synthetic cell images reflect the properties of real ima
100 in phase-separated membrane domains of model synthetic cells, imitating the localization of multimeri
101 d present activated release of material from synthetic cells in a light-sensitive fashion.
102 ological conditions and their suitability as synthetic cells in biological media.
103 s associated with increased calcification of synthetic cells in response to high extracellular Ca(2+)
104     A relatively unexplored energy source in synthetic cells is transmembrane electron transport, whi
105 ith good spatial and temporal control within synthetic, cell-laden biomimetic scaffolds.
106 w available to generate rudimentary forms of synthetic cell-like entities, minimal progress has been
107  controlled drug release and the building of synthetic cell-like or logic ionic networks.
108                         Larger assemblies of synthetic cells may be used to form prototissues.
109                       Under irradiation, the synthetic cell membranes can interact with chemical buil
110              Combining these systems enables synthetic cell microreactors to be built using a nested
111 t microfluidic system for the fabrication of synthetic cells mimicking the viscoelastic and T-cell-ac
112                         Here, we fabricate a synthetic cell-mimicking microparticle (CMMP) that recap
113  a simple method for the de novo creation of synthetic cell mimics in the form of giant polymeric ves
114  Here, we design and assemble a monolayer of synthetic cell-mimics and examine their collective behav
115 e-induced vasodilation by constructing a new synthetic cell model based on bio-derived coacervate ves
116                         We screen a range of synthetic cell models for their ability to form augmente
117                                              Synthetic cell models help us understand living cells an
118 ent work and challenges in developing these "synthetic cell" models and their growing practical appli
119 ide opportunities for the fabrication of new synthetic cell modules and augmented living/synthetic ce
120 gineering synthetic cellular communities and synthetic cell-natural cell communication.
121 ulating blood sugar; and the construction of synthetic 'cells' or particles mimicking functional aspe
122 assive simulations of particles diffusing in synthetic cells parameterized by morphometric statistics
123  of complex biological pathways and use with synthetic cells, particularly using remote, nondamaging
124                                              Synthetic cell permeable C2-ceramide induced apoptotic d
125 in/TCF-dependent transcription, we developed synthetic cell-permeable analogs of beta-catenin's helix
126 ence of N-acetylsphingosine (C2-ceramide), a synthetic cell-permeable ceramide analog.
127                                              Synthetic cell-permeable ceramides (C6- and C2-ceramide)
128 ules that can be oligomerized in vivo by the synthetic cell-permeable dimerizer FK1012H2.
129 urthermore, treating BMECs with cavtratin, a synthetic cell-permeable peptide encoding the caveolin-1
130 3-methyl-but-2-enyl diphosphate (HMBPP) or a synthetic cell-permeable prodrug, bis (pivaloyloxymethyl
131 everal families of readily prepared, totally synthetic, cell-permeable dimerizers composed of ligands
132 s available, control of gene expression with synthetic, cell-permeable molecules is within reach.
133 nto IGCs, and addition of a newly developed, synthetic, cell-permeable P/CAF inhibitor blocks this mo
134            These findings demonstrate that a synthetic, cell-permeable small-molecule can be develope
135                 Here we report the design of synthetic, cell-permeable, stabilized alpha-helical pept
136 inds and stabilizes the fluorescent state of synthetic cell permeant fluorogenic chromophores (so-cal
137 ication, dendritic MCM emerge as a promising synthetic cell platform for the selective delivery of th
138 eration T cell therapies by the induction of synthetic cell programmes.
139 ever, recent progress toward the creation of synthetic cells, ranging from simple protocells to artif
140              But what kind of entity would a synthetic cell really be?
141    The programmed construction of functional synthetic cells requires spatial control over arrays of
142               Routinizing the engineering of synthetic cells requires specifying beforehand how many
143 nimal reactive precursors is a major goal in synthetic cell research.
144               The remodeled light-responsive synthetic cells reversibly alter their shape under irrad
145 t would be valuable in synthetic biology and synthetic cell science.
146 ic biology has stimulated the development of synthetic cells (SCs), autonomous protein-manufacturing
147 ch sophisticated behaviors in liposome-based synthetic cells (SCs).
148  how the model may be deployed to design new synthetic cell signaling circuits based on a desired fin
149                                              Synthetic cells spark intriguing questions about the nat
150 nded to other applications in the context of synthetic cells such as transport, signaling, and contro
151                                The resulting synthetic cells support robust T cell activation and exp
152                                              Synthetic cell surface receptors have potential applicat
153 nce of inter- and extracellular adhesion and synthetic cell surface tension are key material properti
154 emonstrate the first production of a totally synthetic cell-surface receptor for a virus.
155                                              Synthetic cells (SynCells) are artificial constructs des
156                  Here, we describe a dynamic synthetic cell system assembled using artificial lipids
157                           This method yields synthetic cells (tentatively neurons and astrocytes) tha
158 ort the development of temperature-sensitive synthetic cells that control protein production by explo
159 dergo phenotypic conversion to proliferative synthetic cells that generate extracellular matrix to fo
160 hetic biology have led to the development of synthetic cells that mimic some features of real cells,
161  computational models to generate in silico "synthetic" cells that faithfully mimic the temporal traj
162                                 To produce a synthetic cell, the genome must be transferred from yeas
163  The RNA condensates can be expressed within synthetic cells to produce membrane-less organelles with
164      Replicating cellular functions requires synthetic cells to remain structurally stable in biologi
165 rrent interest in mimicking this behavior in synthetic cells to understand the physical basis of inte
166 dels(2-6), can be used to efficiently design synthetic, cell-type-specific enhancers, starting from r
167 ied settings, engineering stimuli-responsive synthetic cells under genetic regulation is imperative.
168 way for customizable, genetically programmed synthetic cells under thermal control to be used in biot
169  selective transcriptional activation inside synthetic cells, underscoring the potential of Chol-ssDN
170 control the synthesis of biomolecules within synthetic cells using a tissue-penetrating stimulus open
171 sed mechanism for transmembrane signaling in synthetic cells using cholesterol-modified single-strand
172 ngs us closer to the bottom-up generation of synthetic cells using recombinant synthetic biology plat
173                                            A synthetic cell-wall analogue was developed to hijack the
174 structures of the enzyme in complex with two synthetic cell-wall-based ligands, we present for the fi
175 e catalytic domain of LytA in complex with a synthetic cell-wall-based peptidoglycan (PG) ligand that
176 n the design of bacteria with non-canonical "synthetic" cell walls.
177 ng the genetic code converged when the first synthetic cell was created 4 years ago.
178 his work, cell-free protein synthesis within synthetic cells was controlled using light by encoding g
179                                The origin of synthetic cells was further examined by colocalization o
180 g these orthogonal light-activated DNAs into synthetic cells, we used two overlapping patterns of blu
181                                 In this way, synthetic cells were activated remotely, in a spatiotemp
182  increases in the maximum growth rate of the synthetic cells were comparable.
183 ntinuous development of bottom-up engineered synthetic cells, which have become increasingly similar
184  formidable task to construct a true-to-life synthetic cell with high organizational and functional c
185 bottleneck exists preventing the creation of synthetic cells with a defined nucleus-like compartment
186  illustrate an approach for the evolution of synthetic cells with alternative biochemical building bl
187         The protocol includes fabrication of synthetic cells with defined sizes, crosslinking strateg
188    Here, we present an approach for creating synthetic cells with distinct nucleus-like compartments
189                 We envisage that interfacing synthetic cells with engineered, multifunctional DNA nan
190 lved in designing, manipulating and creating synthetic cells with hierarchical organization and funct
191 re a versatile platform for creating minimal synthetic cells with life-like functions.
192 re novel approaches towards the formation of synthetic cells with rigid shells, additive manufacturin

 
Page Top